CONNAUGHT’s TRIPEDIA ACELLULAR PERTUSSIS VACCINE APPROVED FOR DTP IMMUNIZATION STARTING AT 15 MONTHS; FIRM PREDICTS LIMITED INITIAL SUPPLY